A polymorphism in the IL11 gene is associated with ulcerative colitis

Area of Science:

• Genetics
• Immunology
• Gastroenterology

Background:

• Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), involve dysregulated immune responses to gut antigens.
• The NF-kappaB pathway is implicated in IBD pathogenesis, and Interleukin 11 (IL11) exhibits anti-inflammatory properties by downregulating NF-kappaB activation.
• The IL11 gene is a potential candidate for IBD genetic predisposition due to its role in immune regulation.

Purpose of the Study:

• To investigate the association between polymorphisms in the IL11 gene and the genetic predisposition to IBD.
• To evaluate the role of IL11 in the inflammatory processes underlying Crohn's disease and ulcerative colitis.

Main Methods:

• Genotyping of two IL11 gene polymorphisms, including a promoter dinucleotide repeat and a coding region variant (exon 4), was performed.
• Polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis was used for polymorphism detection.
• The study included 222 CD patients, 152 UC patients, and 400 healthy controls.

Main Results:

• A polymorphism in IL11 exon 4 (G335A; R112H) showed no significant association with either CD or UC.
• Frequencies of the IL11.A1 allele and IL11.A1 homozygous genotype were significantly elevated in UC patients compared to controls (P < 0.002 and P < 0.003, respectively).
• No significant association was found between IL11 polymorphisms and Crohn's disease susceptibility.

Conclusions:

• Altered expression or function of IL11 may contribute to the genetic predisposition of ulcerative colitis.
• The IL11 gene, particularly its promoter region, plays a role in the susceptibility to UC.
• Further research is warranted to elucidate the precise mechanisms by which IL11 influences IBD pathogenesis.